ELAN Stock Analysis: Buy, Sell, or Hold?
ELAN - Elanco Animal Health Incorporated Common Stock
$25.14
0.32 (1.29%)
▲
5d:
+0.04%
30d:
+9.93%
90d:
+8.69%
BUY
MODERATE Confidence
Analysis Updated: Jul 13, 2026 12:00 AM ET
Earnings: Aug 05, 2026
21d
Get Alerted When ELAN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: ELAN shows positive signals but monitor for confirmation. Market pricing in 0.3% growth. Moderate conviction.
💡 BUY OPPORTUNITY: ELAN shows positive signals but monitor for confirmation. Market pricing in 0.3% growth. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$35.95
Based on 7.6% avg growth
INTRINSIC VALUE TODAY
$22.32
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 21.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: ELAN is currently trading at $25.14, which is considered extended relative to its 30-day fair value range of $23.71 to $24.85. The stock's valuation (Forward PE: 21.2) is in line with its historical norms (21.0). At these levels, the market is pricing in 0.3% annual earnings growth.
Technical Outlook: Technically, ELAN is showing sideways momentum. The price is approaching resistance at $25.33. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: ELAN has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $29.86 (+18.8%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, ELAN is showing sideways momentum. The price is approaching resistance at $25.33. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: ELAN has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $29.86 (+18.8%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$23.71 -
$24.85
Company Quality Score
59/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
62.9%
All Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($29.86)
- BULLISH: Expecting earnings turnaround to 0.3% growth with 14.9% revenue growth
Trading Range Analysis
30-Day Trading Range
$23.71 -
$24.85
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$23.73
Resistance Level
$25.33
Current Trend
Sideways
Technical data as of
Jul 13, 2026
Fundamental Context
Forward P/E (Next Year Est.)
21.20
Wall Street Target
$29.86
(+18.8%)
Revenue Growth (YoY)
14.9%
Earnings Growth (YoY)
-15.4%
Profit Margin
-5.0%
Valuation Premium vs History
+0.3% premium
PE vs Historical
21.2 vs 21.0
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+0.3%
(market-implied from PE analysis)
1-Year Target
$25.22
(+0%)
2-Year Target
$25.29
(+1%)
3-Year Target
$25.37
(+1%)
3-Yr Target (if PE normalizes)
(PE: 21→21)
PE COMPRESSION
$25.13
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 21.8, Growth: 11.3%)
$35.59
(+42%)
Base:
(SPY PE: 21.2, Growth: 11.3%)
$34.64
(+38%)
Bear:
(PE: 18.0, Growth: 11.3%)
$29.45
(+17%)
Share & Embed Analysis
Last updated: July 14, 2026 6:39 AM ET
Data refreshes hourly during market hours. Next update: 7:39 AM
Data refreshes hourly during market hours. Next update: 7:39 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ELAN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences I… |
STRONG BUY
25 analysts |
$198 | 67 BUY |
|
ZTS
Zoetis Inc |
BUY
20 analysts |
$116 | 59 HOLD |
|
UTHR
United Therapeutics Corp… |
STRONG BUY
15 analysts |
$664 | 58 HOLD |
|
LNTH
Lantheus Holdings Inc |
STRONG BUY
13 analysts |
$110 | 51 HOLD |
|
BCRX
BioCryst Pharmaceuticals… |
STRONG BUY
12 analysts |
$22 | 55 HOLD |
Advanced ELAN Option Strategies
Professional options setups generated by AI based on today's ELAN price and gamma walls.
